NO20013731L - Diazabicykliske derivater som nikotinacetylkolinreseptorligander - Google Patents

Diazabicykliske derivater som nikotinacetylkolinreseptorligander

Info

Publication number: NO20013731L
Authority: NO; Norway
Prior art keywords: group; covalent bond; acetylcholine receptor; receptor ligands; nicotinic acetylcholine
Prior art date: 1999-01-29

Application number

NO20013731A

Other languages

English (en)

Norwegian (no)

Other versions

NO20013731D0 (no

Inventor

William H Bunnelle

Daniela Barlocco Cristina

Jerome F Daanen

Michael J Dart

Michael D Meyer

Keith B Ryther

Michael R Schrimpf

Kevin B Sippy

Richard B Toupence

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-29

Filing date

2001-07-30

Publication date

2001-09-18

2001-07-30 Application filed by Abbott Lab filed Critical Abbott Lab

2001-07-30 Publication of NO20013731D0 publication Critical patent/NO20013731D0/no

2001-09-18 Publication of NO20013731L publication Critical patent/NO20013731L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20013731A 1999-01-29 2001-07-30 Diazabicykliske derivater som nikotinacetylkolinreseptorligander NO20013731L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23983899A	1999-01-29	1999-01-29
PCT/US2000/001620 WO2000044755A1 (fr)	1999-01-29	2000-01-25	Derives diazabicycliques utiles en tant que ligands du recepteur nicotinique de l'acetylcholine

Publications (2)

Publication Number	Publication Date
NO20013731D0 NO20013731D0 (no)	2001-07-30
NO20013731L true NO20013731L (no)	2001-09-18

Family

ID=22903947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20013731A NO20013731L (no)	1999-01-29	2001-07-30	Diazabicykliske derivater som nikotinacetylkolinreseptorligander

Country Status (26)

Country	Link
EP (2)	EP1147112B1 (fr)
JP (1)	JP4676062B2 (fr)
KR (1)	KR20010101725A (fr)
CN (2)	CN1345320A (fr)
AR (1)	AR034538A1 (fr)
AT (2)	ATE394401T1 (fr)
AU (1)	AU773795B2 (fr)
BG (1)	BG105836A (fr)
BR (1)	BR0007664A (fr)
CA (1)	CA2361525C (fr)
CO (1)	CO5150231A1 (fr)
CZ (1)	CZ20012716A3 (fr)
DE (2)	DE60038823D1 (fr)
DK (1)	DK1147112T3 (fr)
ES (2)	ES2209825T3 (fr)
HK (1)	HK1043116B (fr)
HU (1)	HUP0200332A3 (fr)
IL (1)	IL144340A0 (fr)
NO (1)	NO20013731L (fr)
NZ (1)	NZ512884A (fr)
PT (1)	PT1147112E (fr)
SK (1)	SK10692001A3 (fr)
TR (1)	TR200102162T2 (fr)
TW (1)	TW200300021A (fr)
WO (1)	WO2000044755A1 (fr)
ZA (1)	ZA200105835B (fr)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6605610B1 (en) *	1997-12-31	2003-08-12	Pfizer Inc	Aryl fused azapolycyclic compounds
HRP20050506A2 (en) *	1997-12-31	2006-03-31	Pfizer Products Inc.	Aryl fused azapolycyclic compounds
ATE289607T1 (de)	1999-12-14	2005-03-15	Neurosearch As	Neue heteroaryl-diazabizykloalkane
MY145722A (en) *	2000-04-27	2012-03-30	Abbott Lab	Diazabicyclic central nervous system active agents
US6809105B2 (en)	2000-04-27	2004-10-26	Abbott Laboratories	Diazabicyclic central nervous system active agents
JP2003534344A (ja)	2000-05-25	2003-11-18	ターガセプト，インコーポレイテッド	ニコチン性コリン受容体リガンドとしてのヘテロアリールジアザビシクロアルカン
US6440970B1 (en)	2000-05-25	2002-08-27	Targacept, Inc.	Pharmaceutical compositions and methods for use
US7060699B2 (en)	2000-07-04	2006-06-13	Neurosearch A/S	Aryl and heteroaryl diazabicycloalkanes, their preparation and use
US6624167B1 (en)	2000-08-04	2003-09-23	Targacept, Inc.	Pharmaceutical compositions and methods for use
DE60202667T2 (de) *	2001-03-02	2005-06-16	Neurosearch A/S	Neue 2,5-diazabicyclo [2.2.1] heptanderivate
WO2002096911A1 (fr) *	2001-06-01	2002-12-05	Neurosearch A/S	Nouveaux heteroaryl-diazabicyclo-alcanes a titre de modulateurs du snc
AR036041A1 (es) *	2001-06-12	2004-08-04	Upjohn Co	Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
US7390813B1 (en)	2001-12-21	2008-06-24	Xenon Pharmaceuticals Inc.	Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
EP1472248A1 (fr)	2002-01-17	2004-11-03	Eli Lilly And Company	Modulateurs de recepteurs de l'acetylcholine
DE60310548T2 (de) *	2002-05-07	2007-05-10	Neurosearch A/S	Diazabicyclische biarylderivate
US7135484B2 (en)	2002-08-14	2006-11-14	Abbott Laboratories	Azabicyclic compounds are central nervous system active agents
US20040242641A1 (en) *	2003-05-27	2004-12-02	Buckley Michael J.	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
ES2386354T3 (es)	2003-07-29	2012-08-17	Xenon Pharmaceuticals Inc.	Derivados de piridilo y su uso como agentes terapéuticos
US7335658B2 (en)	2003-07-30	2008-02-26	Xenon Pharmaceuticals Inc.	Pyridazine derivatives and their use as therapeutic agents
US7399765B2 (en)	2003-09-19	2008-07-15	Abbott Laboratories	Substituted diazabicycloalkane derivatives
US20050065178A1 (en) *	2003-09-19	2005-03-24	Anwer Basha	Substituted diazabicycloakane derivatives
WO2005054209A1 (fr)	2003-11-20	2005-06-16	Janssen Pharmaceutica N.V.	2-quinolinones et 2 quinoxalinones a substitution 7-phenylalkyl tenant lieu d'inhibiteurs de poly(adp-ribose) polymerase inhibitors
US7855207B2 (en)	2003-11-20	2010-12-21	Janssen Pharmaceutica, Nv	6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors
EP1697378B1 (fr) *	2003-12-22	2007-11-21	Memory Pharmaceuticals Corporation	Indoles, 1h-indazoles, 1,2-benzisoxazoles, et 1,2-benzisothiazoles, et leur preparation et utilisation
EP1713487B1 (fr)	2004-02-04	2009-12-02	Neurosearch A/S	Derives d'aryle diazabicycliques constituant des modulateurs des recepteurs cholinergiques
US7365193B2 (en)	2004-02-04	2008-04-29	Abbott Laboratories	Amino-substituted tricyclic derivatives and methods of use
US20050171079A1 (en) *	2004-02-04	2005-08-04	Schrimpf Michael R.	Amino-substituted tricyclic derivatives and methods of use
EP1742944B1 (fr)	2004-04-22	2010-11-10	Memory Pharmaceuticals Corporation	Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, leur preparation et leurs utilisations
ITMI20040954A1 (it) *	2004-05-12	2004-08-12	Univ Degli Studi Milano	Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
MXPA06014541A (es)	2004-06-30	2007-03-23	Janssen Pharmaceutica Nv	Derivados de quinazolindiona como inhibidores de la poli(adp-ribosa) polimerasa.
WO2006003146A1 (fr)	2004-06-30	2006-01-12	Janssen Pharmaceutica N.V.	Derives de quinazolinone en tant qu'inhibiteurs de parp
US7803795B2 (en)	2004-06-30	2010-09-28	Janssen Pharmaceutica N.V.	Phthalazine derivatives as parp inhibitors
JP5254616B2 (ja)	2004-09-13	2013-08-07	クロノセラピューティクス、インコーポレイテッド	生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
AU2005286728A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
AR051026A1 (es)	2004-09-20	2006-12-13	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
BRPI0515505A (pt)	2004-09-20	2008-07-29	Xenon Pharmaceuticals Inc	derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
AU2005286648A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
WO2006034341A2 (fr)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
MX2007003321A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como agentes terapeuticos.
CA2580857A1 (fr)	2004-09-20	2006-09-28	Xenon Pharmaceuticals Inc.	Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
WO2006087305A1 (fr)	2005-02-16	2006-08-24	Neurosearch A/S	Derives aryle diazabicycliques et utilisation medicale
US7662812B2 (en)	2005-02-16	2010-02-16	Neurosearch A/S	Diazabicyclic aryl derivatives and their use as chinolinergic ligands at nicotinic acetylcholine receptors
MX2007015216A (es)	2005-06-03	2008-02-22	Xenon Pharmaceuticals Inc	Derivados de aminotiazol y sus usos como agentes terapeuticos.
EP2246352A1 (fr) *	2005-12-06	2010-11-03	NeuroSearch AS	Derives innovants d'aryle diazabicyclique et leur utilisation medicale
CN101448828B (zh) *	2006-02-10	2011-12-07	神经研究公司	作为烟碱性乙酰胆碱受体激动剂的3-杂芳基-3,9-二氮杂双环[3.3.1]壬烷衍生物
WO2007090887A1 (fr) *	2006-02-10	2007-08-16	Neurosearch A/S	Dérivés de 3, 9-diazabicyclo [3.3. 1]nonane et leur utilisation en tant qu'inhibiteurs de réabsorption de neurotransmetteur de monoamine
CA2641685A1 (fr)	2006-02-10	2007-08-16	Neurosearch A/S	Derives de 3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane utilises en tant qu'agonistes du recepteur nicotinique de l'acetylcholine
US7700596B2 (en)	2006-02-10	2010-04-20	Neurosearch A/S	3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2007093601A1 (fr) *	2006-02-14	2007-08-23	Neurosearch A/S	Dérivés de 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl méthanone en tant qu'agonistes du récepteur nicotinique de l'acétylcholine
US20090075983A1 (en) *	2006-02-14	2009-03-19	Dan Peters	Novel Diazabicycloalkane Derivatives and Their Medical Use
CA2647830C (fr)	2006-05-19	2016-02-09	Abbott Laboratories	Derives d'alcane azabicyclique substitues par un bicycloheterocycle fusionne actif pour le systeme nerveux central
WO2007135121A1 (fr)	2006-05-23	2007-11-29	Neurosearch A/S	Nouveaux dérivés de 8,10-diaza-bicyclo[4.3.1]décane et leur utilisation médicale
WO2008008517A2 (fr)	2006-07-14	2008-01-17	Merck & Co., Inc.	Diazépans pontés antagonistes du récepteur de l'oréxine
US8076350B2 (en)	2006-12-22	2011-12-13	Abbott Laboratories	Spirocyclic azaadamantane derivatives and methods of use
HRP20120346T1 (hr)	2007-03-08	2012-05-31	Janssen Pharmaceutica N.V.	Derivati kinolinona kao parp i tank inhibitori
EP2322167A1 (fr)	2007-04-02	2011-05-18	Parkinson's Institute	Procédés et compositions pour la réduction des effets indésirables de traitements thérapeutiques
JP2010527924A (ja) *	2007-05-18	2010-08-19	メルク・シャープ・エンド・ドーム・コーポレイション	オキソ架橋ジアゼパンオレキシン受容体アンタゴニスト
EP2215075B1 (fr)	2007-10-26	2013-12-11	Janssen Pharmaceutica, N.V.	Dérivés de quinolinone en tant qu'inhibiteurs parp
WO2009081246A2 (fr) *	2007-12-19	2009-07-02	Pfizer Inc.	Diamines bicycliques en tant qu'agonistes de récepteur nicotinique
WO2009118382A1 (fr)	2008-03-27	2009-10-01	Janssen Pharmaceutica Nv	Tétrahydrophénanthridinones et tétrahydrocyclopentaquinolinones comme inhibiteurs de la polymérisation de la tubuline et de parp
JP5464609B2 (ja)	2008-03-27	2014-04-09	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	チューブリン重合阻害剤としてのキナゾリノン誘導体
US8148408B2 (en)	2008-05-09	2012-04-03	Abbott Laboratories	Selective substituted pyridine ligands for neuronal nicotinic receptors
TW201004963A (en) *	2008-07-03	2010-02-01	Targacept Inc	Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
CA2738806A1 (fr) *	2008-10-14	2010-04-22	Psychogenics, Inc.	Ligands des recepteurs cholinergiques nicotiniques et leurs utilisations
KR101925971B1 (ko) *	2011-01-28	2018-12-06	에스케이바이오팜 주식회사	피리돈 유도체 및 이를 포함하는 약학적 조성물
WO2013016160A1 (fr) *	2011-07-26	2013-01-31	Merck Sharp & Dohme Corp.	Dérivés inédits d'imidazo[1,2-a]pyrazine utilisables en tant qu'inhibiteurs de mtor
WO2013050938A1 (fr) *	2011-10-04	2013-04-11	Actelion Pharmaceuticals Ltd	Dérivés de 3,7-diazabicyclo[3.3.1]nonane et de 9-oxa-3,7- diazabicyclo[3.3.1]nonane
WO2013116413A1 (fr) *	2012-02-02	2013-08-08	Targacept, Inc.	Diazabicyclo[3.3.1]nonanes, leurs procédés de synthèse et leurs utilisations
CN102952134B (zh) *	2012-12-05	2015-01-07	苏州药明康德检测检验有限责任公司	含二氟甲基的金雀花碱衍生物及制备方法和抗癌作用研究
WO2016054123A1 (fr)	2014-09-30	2016-04-07	Lightner Derek	Procédés de production d'hétéropolycycles par bis-époxydation
CA2974324A1 (fr)	2015-01-28	2016-08-04	Zita S. Netzel	Procedes et systemes d'administration de medicament
CA3049529A1 (fr)	2017-01-06	2018-07-12	Chrono Therapeutics Inc.	Dispositifs et methodes d'administration transdermique de medicament
US20180311238A1 (en) *	2017-04-28	2018-11-01	Saniona A/S	Selective Agonist Of a6 Containing nAChRs
JP7420797B2 (ja)	2018-05-29	2024-01-23	モーニングサイドベンチャーインベストメンツリミテッド	薬剤送達の方法及びシステム
EP3880175A4 (fr)	2018-11-16	2022-08-17	Morningside Venture Investments Limited	Système d'administration transdermique de médicaments à régulation thermique
AR117169A1 (es)	2018-11-28	2021-07-14	Bayer Ag	(tio)amidas de piridazina como compuestos fungicidas
EA202191668A1 (ru)	2018-12-20	2021-11-10	Байер Акциенгезельшафт	Гетероциклил пиридазин в качестве фунгицидных соединений
US20230165252A1 (en)	2020-05-27	2023-06-01	Bayer Aktiengesellschaft	Active compound combinations
US20240016152A1 (en)	2020-06-18	2024-01-18	Bayer Aktiengesellschaft	Active compound combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5478939A (en) *	1994-07-20	1995-12-26	American Cyanamid Company	(R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
SK284994B6 (sk) *	1997-05-30	2006-04-06	Neurosearch A/S	Deriváty 8-azabicyklo[3.2.1]okt-2-énu, spôsob ich prípravy a ich použitie
EP0984966B1 (fr) *	1997-05-30	2003-01-29	Neurosearch A/S	Derives de 9-azabicyclo(3.3.1)non-2-ene et nonane utilises comme ligands cholinergiques de recepteurs nicotiniques de l'ach.
FR2786769B1 (fr) *	1998-12-04	2002-10-25	Synthelabo	Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique

2000
- 2000-01-25 IL IL14434000A patent/IL144340A0/xx unknown
- 2000-01-25 CA CA002361525A patent/CA2361525C/fr not_active Expired - Fee Related
- 2000-01-25 JP JP2000596011A patent/JP4676062B2/ja not_active Expired - Fee Related
- 2000-01-25 AT AT03017562T patent/ATE394401T1/de not_active IP Right Cessation
- 2000-01-25 NZ NZ512884A patent/NZ512884A/xx unknown
- 2000-01-25 PT PT00906998T patent/PT1147112E/pt unknown
- 2000-01-25 CN CN00805544A patent/CN1345320A/zh active Pending
- 2000-01-25 AT AT00906998T patent/ATE253067T1/de active
- 2000-01-25 AU AU28569/00A patent/AU773795B2/en not_active Ceased
- 2000-01-25 CN CNA2004100974823A patent/CN1636996A/zh active Pending
- 2000-01-25 TR TR2001/02162T patent/TR200102162T2/xx unknown
- 2000-01-25 SK SK1069-2001A patent/SK10692001A3/sk unknown
- 2000-01-25 CZ CZ20012716A patent/CZ20012716A3/cs unknown
- 2000-01-25 DK DK00906998T patent/DK1147112T3/da active
- 2000-01-25 BR BR0007664-3A patent/BR0007664A/pt not_active IP Right Cessation
- 2000-01-25 KR KR1020017009420A patent/KR20010101725A/ko not_active Ceased
- 2000-01-25 WO PCT/US2000/001620 patent/WO2000044755A1/fr not_active Ceased
- 2000-01-25 EP EP00906998A patent/EP1147112B1/fr not_active Expired - Lifetime
- 2000-01-25 DE DE60038823T patent/DE60038823D1/de not_active Expired - Lifetime
- 2000-01-25 EP EP03017562A patent/EP1359152B1/fr not_active Expired - Lifetime
- 2000-01-25 ES ES00906998T patent/ES2209825T3/es not_active Expired - Lifetime
- 2000-01-25 HK HK02102948.7A patent/HK1043116B/en not_active IP Right Cessation
- 2000-01-25 DE DE60006213T patent/DE60006213T2/de not_active Expired - Lifetime
- 2000-01-25 HU HU0200332A patent/HUP0200332A3/hu unknown
- 2000-01-25 ES ES03017562T patent/ES2305373T3/es not_active Expired - Lifetime
- 2000-01-26 CO CO00004294A patent/CO5150231A1/es unknown
- 2000-01-28 AR ARP000100393A patent/AR034538A1/es not_active Application Discontinuation
- 2000-03-01 TW TW091133012A patent/TW200300021A/zh unknown
2001
- 2001-07-16 ZA ZA200105835A patent/ZA200105835B/en unknown
- 2001-07-30 NO NO20013731A patent/NO20013731L/no not_active Application Discontinuation
- 2001-08-22 BG BG105836A patent/BG105836A/xx unknown

Also Published As

Publication number	Publication date
EP1359152B1 (fr)	2008-05-07
NO20013731D0 (no)	2001-07-30
AU773795B2 (en)	2004-06-03
HK1043116B (en)	2004-10-15
IL144340A0 (en)	2002-05-23
CN1345320A (zh)	2002-04-17
CO5150231A1 (es)	2002-04-29
DE60038823D1 (de)	2008-06-19
HUP0200332A3 (en)	2002-09-30
EP1147112A1 (fr)	2001-10-24
JP4676062B2 (ja)	2011-04-27
BG105836A (en)	2002-03-29
DK1147112T3 (da)	2004-02-23
CA2361525A1 (fr)	2000-08-03
SK10692001A3 (sk)	2002-01-07
DE60006213D1 (de)	2003-12-04
CA2361525C (fr)	2009-12-08
BR0007664A (pt)	2002-05-07
HK1043116A1 (en)	2002-09-06
AR034538A1 (es)	2004-03-03
ES2209825T3 (es)	2004-07-01
ATE253067T1 (de)	2003-11-15
NZ512884A (en)	2004-03-26
WO2000044755A1 (fr)	2000-08-03
KR20010101725A (ko)	2001-11-14
ZA200105835B (en)	2002-10-16
EP1359152A2 (fr)	2003-11-05
EP1359152A3 (fr)	2003-12-17
EP1147112B1 (fr)	2003-10-29
PT1147112E (pt)	2004-03-31
ATE394401T1 (de)	2008-05-15
AU2856900A (en)	2000-08-18
TR200102162T2 (tr)	2001-12-21
HUP0200332A2 (en)	2002-06-29
JP2002535409A (ja)	2002-10-22
TW200300021A (en)	2003-05-01
ES2305373T3 (es)	2008-11-01
CN1636996A (zh)	2005-07-13
DE60006213T2 (de)	2004-07-29
CZ20012716A3 (cs)	2001-11-14

Publication	Publication Date	Title
NO20013731L (no)	2001-09-18	Diazabicykliske derivater som nikotinacetylkolinreseptorligander
DK0870768T3 (da)	2002-07-01	Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
MY126736A (en)	2006-10-31	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
NO20056196L (no)	2005-12-28	Makrocykliske kinazolinderivater som antiproliferative midler
NZ514477A (en)	2003-04-29	Adamantane derivatives
MY107756A (en)	1996-06-15	Piperazine derivatives.
GB2369360A (en)	2002-05-29	5-cyano-2-aminopyrimidine derivatives
CA2339630A1 (fr)	2000-03-23	Derives de carboline en tant qu'inhibiteurs de la gmp cyclique phosphodiesterase
NO996108L (no)	2000-02-10	9-oksinerytromycinderivater
IL190780A0 (en)	2008-11-03	Heterocyclic substituted aminoazacycles useful as central nervous system agents
CA2295088A1 (fr)	1999-01-21	Benzamides bicycliques gastrocinetiques de derives 4-(aminomethyle)-piperidine substitues en 3 ou en 4
TW333527B (en)	1998-06-11	Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
NO20044606L (no)	2004-10-26	Polymorfe former av lansoprazol og fremgangsmater for fremstilling derav
AU5705700A (en)	2001-01-22	Crystals of benzimidazole compounds
CA2361614A1 (fr)	2000-08-03	Compositions permettant de traiter une reponse inflammatoire
PT1181299E (pt)	2008-09-18	Derivados de eritromicina modificados em c-2
WO2001094345A3 (fr)	2002-07-18	Composes chimiques
IL163625A0 (en)	2005-12-18	Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same
TR200001141T2 (tr)	2001-02-21	Motilin reseptörü antagonistleri olarak yararlı siklopenten türevleri.
MY117092A (en)	2004-05-31	Chemotherapeutic pyrrolocarbazole derivatives
MXPA05005198A (es)	2005-08-18	Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina.
IL136911A0 (en)	2001-06-14	Heterocyclic topoisomerase poisons
IL151198A0 (en)	2003-04-10	Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
BG103735A (en)	2000-06-30	Method for the preparation of substituted thiazolidindions
CA2374902A1 (fr)	2000-12-14	Derives de benzopyrane substitues par un aminoalkyle pour le traitement de la relaxation gastrique

Legal Events

Date	Code	Title	Description
2005-10-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application